UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 1217, 2025

Anteris Technologies Global Corp.

(Exact name of registrant as specified in its charter)

Delaware		001-42437		99-1407174
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Toowong Tower, Level 3, Suite 302 9 Sherwood Road Toowong, QLD Australia		4066
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +61 7 3152 3200

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		AVR		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 27.0201. ~~Results~~Regulation ofFD ~~Operations and Financial Condition.~~Disclosure

On November 1216, 2025 ~~USA ET~~ (November 1317, 2025 ~~AEST~~AEDT), Anteris Technologies Global Corp. (the “Company”) ~~(i) filed the Form 10-Q for the quarter ended September 30, 2025 with a cover page (the “Results Announcement”) with the Australian Securities Exchange (“ASX”); and (ii)~~ issued an ASX Announcement ~~regarding~~and ~~the~~on ~~Company’s~~November ~~financial results for the quarter ended September 30~~17, 2025, ~~both~~issued ofa ~~which~~press ~~include~~release ~~unaudited~~presenting ~~and other historical financial information for~~ the ~~quarter ended September~~ 30,-day ~~2025.~~clinical ~~The~~outcomes ~~Results Announcement has been prepared~~ for the ~~purpose~~DurAVR® ofTranscatheter ~~complying~~Heart ~~with~~Valve ~~the~~(THV) ~~reporting~~in ~~requirements~~one ofhundred ~~the~~severe ~~ASX.~~aortic ~~Copies~~stenosis ofpatients ~~the Results~~with ~~Announcement~~small ~~and~~aortic ~~the ASX Announcement are attached as Exhibits 99~~annuli.~~1 and 99.2, respectively, to this Current Report on Form 8-K.~~

The information in this ~~Item~~Current ~~2.02,~~Report ~~including~~on ~~Exhibits~~Form ~~99.1~~8-K, ~~and~~including ~~99.2~~the exhibit attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, unless such subsequent filing specifically ~~references~~ references this Current Report on Form 8-K.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed with this Current Report on Form 8-K:

Exhibit No.		Description
99.1		~~Results~~ASX ~~Announcement,~~announcement: asAnteris ~~filed~~Technologies ~~with~~Presents ~~the~~Data ~~ASX,~~from ~~for~~100 ~~the~~DurAVR® ~~quarter~~THV ~~ended~~Patients ~~September~~at ~~30,~~PCR ~~2025~~London Valves
99.2		ASX Announcement regarding financial results for the quarter ended September 30, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Anteris Technologies Global Corp.
Date: November 12, 2025
Date: November 17, 2025
	By:	/s/ Wayne Paterson
	Name:	Wayne Paterson
	Title:	~~Vice Chairman and~~ Chief Executive Officer

Filing Compare · Anteris Technologies Global Corp.